Literature DB >> 2532620

Cell-cell interactions for CD23 expression and soluble CD23 release from peripheral lymphocytes of atopic donors.

K Kicza1, A Fischer, T Pfeil, J Bujanowski-Weber, W König.   

Abstract

The cell-cell interactions for CD23 expression and soluble (s)CD23 release from peripheral blood lymphocytes (PBL), as well as purified cells (B, T cells, monocytes) of atopic donors, were studied. Cells either stimulated combined and subsequently separated or stimulated after separation were analysed. IL-4, IL-2, phytohaemagglutinin (PHA), interferon-gamma (IFN-gamma) and the combined interaction of IL-4 and IFN-gamma as well as PHA and IFN-gamma were used as stimuli. sCD23 release in the cell supernatant was determined from cells separated before stimulation. CD23 expression induced by IL-4 on cells stimulated and subsequently separated was significantly lower compared with amounts on separated cells which were subsequently stimulated. Major expression of CD23 was obtained on B cells and monocytes. Stimulation with PHA led to an increased expression on T cells compared to the control. When cells were stimulated, combined and separated, the combined stimuli of IL-4 and IFN-gamma showed a reduced CD23 expression for both experimental procedures and an enhanced release of sCD23. The data suggest an important role for cell-cell interactions. These results were supported by experiments in which separated cells were either co-cultured or cultured in Transwells. Co-culture of T cells with B cells and monocytes suggested that T cells are responsible for suppressed CD23 expression. No or only slight enhancement was obtained for sCD23 release. Our data indicate that cell-cell interactions and cytokines regulate CD23 expression, while sCD23 release is apparently solely regulated by soluble mediators (e.g. cytokines).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532620      PMCID: PMC1385543     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

2.  General methods for the study of cells and serum during the immune response: the response to dinitrophenyl in mice.

Authors:  N R Klinman; R B Taylor
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

3.  Characterization with monoclonal antibodies of T lymphocytes bearing Fc receptors for IgE (T epsilon cells) and IgG (T gamma cells) in atopic patients.

Authors:  L F Thompson; M H Mellon; R S Zeiger; H L Spiegelberg
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

4.  Rapid identification of monocytes in a mixed mononuclear cell preparation.

Authors:  S B Tucker; R V Pierre; R E Jordon
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

5.  Lymphocytes with immunoglobulin E Fc receptors in patients with atopic disorders.

Authors:  H L Spiegelberg; R D O'Connor; R A Simon; D A Mathison
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

6.  A subpopulation of normal human peripheral B lymphcytes that bind IgE.

Authors:  A Gonzalez-Molina; H L Spiegelberg
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

7.  Role of IgE receptors in effector function of human eosinophils.

Authors:  M Capron; H L Spiegelberg; L Prin; H Bennich; A E Butterworth; R J Pierce; M A Ouaissi; A Capron
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

8.  Influence of IL-2 and IL-4 on the IgE synthesis and the IgE-binding factor (sCD23) production by human lymphocytes in vitro.

Authors:  I Knöller; J Bujanowski-Weber; B Brings; W König
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

9.  Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors.

Authors:  J Bujanowski-Weber; B Brings; I Knöller; T Pfeil; W König
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

10.  Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens.

Authors:  D Vercelli; H H Jabara; K Arai; R S Geha
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  4 in total

1.  Altered production of IgE and IgA induced by IL-4 in peripheral blood mononuclear cells from patients with IgA nephropathy.

Authors:  N Yano; M Endoh; M Miyazaki; F Yamauchi; Y Nomoto; H Sakai
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

2.  Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses.

Authors:  T Matsubara; S Furukawa; T Motohashi; K Okumura; K Yabuta
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

3.  Fc epsilon receptor II/CD23+ lymphocytes in atopic dermatitis. III. Aberrant control in the in vitro expression of Fc epsilon RII/CD23 on peripheral blood T cells in atopic dermatitis.

Authors:  T Sakamoto; F Nakayama; T Tamamori; M Takigawa
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

4.  Distinct modulation by interferon-gamma (IFN-gamma) of CD23 expression on B and T lymphocytes of atopic subjects.

Authors:  M Corominas; M Mestre; J Bas; E Buendia
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.